CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulation, 201523-04-2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulation, 2015CHEMO PHARMA LABORATORIES LTD. - 506365 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024
We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024.CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Non-Applicability of Annual Secretarial Compliance Report for the year ended March 31, 2024, under Regulation 24A of SEBI (LODR)Regulations, 2015.CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliance Certificate Pursuant To Regulation 7(3) Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2024
Compliance Certificate Pursuant to Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the Financial Year Ended 31st March 2024.CHEMO PHARMA LABORATORIES LTD. - 506365 - Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
Declaration of Non-applicability of Regulation 23(9) of SEBI (LODR) Regulations, 2015 for the half year ended March 31, 2024.CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the Quarter Ended March 31, 2024CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
Intimation of Trading Window closureCHEMO PHARMA LABORATORIES LTD. - 506365 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Advertisement of Unaudited Financial Results for the Quarter and Nine Months Ended December 31, 2023.CHEMO PHARMA LABORATORIES LTD. - 506365 - Appointment Of M/S Kavita Khatri & Associates Company Secretary As The Secretarial Auditor Of The Company For The Financial Year 2023-24
Appointment of M/s Kavita Khatri & Associates Company Secretary as the Secretarial Auditor of the Company for the Financial Year 2023-24CHEMO PHARMA LABORATORIES LTD. - 506365 - Approval The Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2023 Along With The Limited Review Report Thereon.
Approval the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2023 along with the Limited Review Report thereon.